YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Researcher with pipette ©National Institutes of Health Fractyl Health (NASDAQ:GUTS) shares rose 2.8% in pre-market trading ahead of the company's Virtual Commercial Strategy Day, scheduled for 11:00 AM ET on Tuesday. Management is expected…
BURLINGTON, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a clinical-stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes…
(RTTNews) - This week, the healthcare sector saw multiple U.S FDA and European Commission approvals, strategic licensing and M&A activity, as well as pivotal clinical trial readouts and regulatory setbacks. Positive data readouts spanned m…
Fractyl Health, Inc. GUTS reported positive one-year results from the randomized, sham-controlled Midpoint Cohort of its REMAIN-1 study, demonstrating that the investigational Revita duodenal mucosal resurfacing system helped patients main…
Fractyl Health, Inc. Experienced market access leader joins to build reimbursement and health economic infrastructure for Revita® ahead of anticipated REMAIN-1 Pivotal Cohort topline data in early Q4 2026 BURLINGTON, Mass., June 01, 2026 (…
Gainers Quantum Cyber (NASDAQ:QUCY) shares rose 163.0% to $0.85 during Wednesday's regular session. The market value of their outstanding shares is at $4.0 million. Whitehawk Therapeutics (NASDAQ:WHWK) stock moved upwards by 29.59% to $5.0…
Earnings Call Insights: Fractyl Health (GUTS) Q1 2026 MANAGEMENT VIEW * "Q1 2026 was a quarter of execution and today, I want to reaffirm these 4 commitments" (Co-Founder, CEO & Director Harith Rajagopalan), adding: "Revita is being built…
Key Points Interested in Fractyl Health, Inc.? Here are five stocks we like better. Revita remains on track for pivotal six-month data in early Q4 2026, with the company saying the REMAIN-1 trial has enrolled more than 300 patients and ret…
Fractyl Health logo Key Points New analyses show treatment “dose” — specifically ablation length — drives efficacy, with clear benefit at ≥16 centimeters; in patients with >17.5% run‑in weight loss Revita cut 6‑month post‑GLP‑1 weight rega…
* Fractyl Health press release [https://seekingalpha.com/pr/20449872-fractyl-health-reports-fourth-quarter-and-full-year-2025-financial-results-and-business] (GUTS [https://seekingalpha.com/symbol/GUTS]): Q4 Net Loss: For the quarter ended…
What happened According to its latest SEC filing dated Feb. 13, 2026, Pale Fire Capital SE initiated a new position in Baxter International(NYSE:BAX), purchasing 2,074,016 shares. The estimated transaction value, calculated using the quart…
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Healthcare Triangle Inc. 95,277,247 0.4008 0.3277 0.3302 +0.0288 ENvue Med…
Fractyl Health, Inc. (NASDAQ:GUTS) is one of the 10 Best New Penny Stocks to Invest In. On December 19, Canaccord Genuity reiterated its Buy rating on Fractyl Health, Inc. (NASDAQ:GUTS) with a price target of $8. This comes after a series…
[Stock Market] sweetym/iStock via Getty Images U.S. stock futures retreated Tuesday as investors adopted a cautious stance ahead of November’s employment data, a key indicator for the labor market’s health. Here are some of Tuesday's bigge…
BURLINGTON, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company” or “Fractyl”), a metabolic therapeutics company focused on pioneering pattern-breaking approaches that treat root causes of obesity and…
[Successful diet. Young female in oversized jeans demonstrating results of her slimming] Prostock-Studio * Fractyl Health (GUTS [https://seekingalpha.com/symbol/GUTS]) said that data from an open-label study of its Revita outpatient endosc…
(RTTNews) - Fractyl Health (GUTS) reported new six-month data from its open-label REVEAL-1 cohort, showing that people with obesity who stopped GLP-1 drugs maintained both weight and glycemic control after a single Revita procedure. The co…
Participants who lost 24% total body weight (>50 lbs.) on GLP-1 drugs maintained stable weight 6 months after GLP-1 discontinuation and single Revita treatment 1.5% mean weight change observed with Revita (n=17); published third-party stud…
BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a metabolic therapeutics company focused on pattern-breaking approaches that treat root causes of obesity and type 2 diabete…
Earnings Call Insights: Fractyl Health (GUTS) Q3 2025 MANAGEMENT VIEW * CEO Harith Rajagopalan stated that "this quarter marked a major inflection point for Fractyl. We delivered the first randomized, double-blind, sham-controlled data sho…
BURLINGTON, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes of obesity and type 2 diabetes (T2D),…
* Fractyl Health (NASDAQ:GUTS [https://seekingalpha.com/symbol/GUTS]) on Friday announced [https://seekingalpha.com/pr/20245642-fractyl-health-announces-pricing-of-60-million-underwritten-offering-of-common-stock] the pricing of an underwr…
Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock BURLINGTON, Mass., September 26, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company” or “Fractyl”), a metabolic therapeutics comp…
Pilot study met key 3-month efficacy endpoint with strong statistical significance (p=0.014); Revita-treated patients lost an additional 2.5% total body weight after stopping GLP-1 drugs vs. 10% regain in sham-treated patients Revita proce…
BURLINGTON, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a metabolic therapeutics company focused on pattern breaking approaches that treat root causes of obesity and type 2 diabet…
Investing.com - Canaccord Genuity lowered its price target on Fractyl Health Inc (NASDAQ:GUTS) to $6.00 from $12.00 on Thursday, while maintaining a Buy rating on the stock. The company’s shares currently trade at $1.01, with InvestingPro…
Key Points Net loss (GAAP) widened 62% to $27.9 million compared to Q2 2024, as research and development spending rose 26% over the prior year period. No revenue was reported this quarter, in line with expectations. Clinical programs advan…
Earnings Call Insights: Fractyl Health (GUTS) Q2 2025 MANAGEMENT VIEW * CEO Harith Rajagopalan stated that Fractyl Health is focused on addressing weight regain after GLP-1 discontinuation, describing it as a "massive unmet need because mo…
Investing.com – U.S. stocks were higher after the close on Wednesday, as gains in the Consumer Services, Consumer Goods and Technology sectors led shares higher. At the close in NYSE, the Dow Jones Industrial Average rose 0.19%, while the…
BURLINGTON, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company” or “Fractyl”), a metabolic therapeutics company focused on pattern breaking approaches that treat root causes of obesity and type 2 dia…
Curious about what's happening in today's session? Check out the latest stock movements and price changes. [topmovers] TOP GAINERS TICKER CHANGE COMMENT SGBX [https://www.chartmill.com/stock/quote/SGBX/profile] 86.14% SAFE & GREEN HOLDINGS…
Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis. [topmovers] TOP GAINERS TICKER CHANGE COMMENT GO [https://www.chartmill.com/sto…
Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps. [gap] GAP UP STOCKS TICKER CHANGE COMMENT SGBX [https://www.chartmill.com/stock/quote/SGBX/profile] 117.…
BURLINGTON, Mass. - Fractyl Health, Inc. (NASDAQ:GUTS), a metabolic therapeutics company focused on treatments for obesity and type 2 diabetes, announced Wednesday the pricing of its underwritten public offering of 19,047,619 shares of com…
BURLINGTON, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company” or “Fractyl”), a metabolic therapeutics company pioneering pattern-breaking approaches that treat root causes of obesity and type 2 dia…
As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. [premarket] TODAY'S PRE-MARKET GAINERS TICKER CHANGE COMMENT SGBX [h…